Cytiva-Cell & Gene Therapy WP 2
Q&A: Cell and gene therapy value assessments need a rework to allow access
Paolo Morgese, vice president of European public affairs at the Alliance for Regenerative Medicine, discusses the barriers affecting access to gene therapies.